![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-0.025 | -1.20% | 2.05 | 2.00 | 2.10 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
2.075 | 2.025 | 2.075 | 1,136,277 | 12:36:34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 13.09M | -33.29M | -0.0429 | -0.48 | 16.09M |
Date | Time | Source | Headline |
---|---|---|---|
26/7/2024 | 15:27 | ALNC | ![]() |
24/7/2024 | 07:01 | UK RNS | Shield Therapeutics PLC Unaudited Q2 2024 Trading Update |
24/7/2024 | 07:00 | UK RNS | Shield Therapeutics PLC Directorate Change |
03/7/2024 | 16:26 | ALNC | ![]() |
03/7/2024 | 07:00 | UK RNS | Shield Therapeutics PLC $5.7m Milestone Monetization Agreement with AOP |
20/6/2024 | 16:25 | UK RNS | Shield Therapeutics PLC Results of 2024 Annual General Meeting |
28/5/2024 | 20:32 | ALNC | ![]() |
28/5/2024 | 07:00 | UK RNS | Shield Therapeutics PLC New Drug Application for Accrufer® in South Korea |
10/5/2024 | 15:30 | UK RNS | Shield Therapeutics PLC Audited results for the year ended 31 Dec 2023 |
30/4/2024 | 19:54 | ALNC | ![]() |
1 Year Shield Therapeutics Chart |
Intraday Shield Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions